相关实验视频

Updated: Jul 29, 2025

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

生物学洞察力和神经母细胞瘤治疗的最新进展

Zoriamin Rivera¹, Carlos Escutia¹, Mary Beth Madonna¹

¹Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.

International journal of molecular sciences

|May 27, 2023

概括

神经母细胞瘤是一种常见的儿童癌症,由于其瘤微观环境,它给免疫治疗带来了独特的挑战. 本综述探讨了免疫疗法,包括CAR T细胞疗法,以MYCN和GD2等抗原为目标,以克服这些障碍.

科学领域:

儿科瘤学儿科瘤学
癌症免疫学癌症免疫学
分子生物学分子生物学

背景情况:

神经母细胞瘤是一种常见的儿童固体瘤,具有可变的临床行为.
关键特征包括早期发病,新生儿的自发回归,老年儿童的频繁转移.
免疫疗法,包括CAR T细胞疗法,是一种有前途的治疗方法,但在神经母细胞瘤中面临挑战.

研究的目的:

审查目前针对神经母细胞瘤的免疫治疗策略.
确定神经母细胞瘤瘤微环境 (TME) 中的关键免疫因素和途径.
讨论神经母细胞瘤免疫疗法的挑战和进展.

主要方法:

关于神经母细胞瘤免疫疗法的文献综述.
对分子标的分析,如MYCN和GD2.2.
检查TME内部的免疫逃避机制.

主要成果:

MYCN和GD2是神经母细胞瘤免疫治疗的重要点.
免疫抑制性TME阻碍了有效的免疫反应.
瘤细胞采用策略来逃避免疫监测.

结论:

克服TME介导的免疫抑制对于成功的神经母细胞瘤免疫治疗至关重要.
针对特定的抗原和了解免疫相互作用是推进治疗的关键.
需要对免疫学行为体和途径进行进一步研究.

关键词:

高风险神经母细胞瘤免疫疗法免疫疗法瘤微环境是一个微环境.

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...